ELITechGroup received the CE mark for Saliva on SARS-CoV-2 ELITe MGB® Kit
August 5, 2021
ITALY, Torino, August 3rd, 2021. ELITechGroup is pleased to announce the CE mark for use of saliva on SARS-CoV-2 ELITe MGB® Kit. The collection of saliva matrix is less invasive for SARS-CoV-2 detection than nasopharyngeal swabs and will permit to address different needs starting from repeated screening in various settings such as schools and workplaces.
“ELITechGroup is constantly committed to improving both test quality and sample matrices collected. For this reason, we identified the use of saliva for SARS-CoV-2 as crucial for reopening schools and community life” says Roberto Meda, Vice President MDx ELITechGroup.
The CE-IVD marked Kit detecting SARS-CoV-2 and validated on nasopharyngeal, nasal and oropharyngeal swabs has been released on September 2020 on the Sample-to Result-Platform ELITe InGenius® and on major PCR thermocyclers as well.
About ELITechGroup: ELITechGroup is a privately held group of worldwide manufacturers and distributors of in vitro diagnostic equipment and reagents. By bringing together IVD specialty companies that offer innovative products and solutions, ELITechGroup has become a major contributor in advancing clinical diagnostics to laboratories in the proximity market, those operating closer to the patient.
Recent News
- BioUtah’s 2026 Utah Life Sciences Summit Recap
- 2026 Life Sciences Awards to be Presented at the Mayer Brown Utah Life Sciences Summit
- PROGRESS TRIAL DEMONSTRATES EDWARDS TAVR IS SUPERIOR TO CLINICAL SURVEILLANCE FOR MODERATE AS PATIENTS WITH AT-RISK FEATURES
- Denali Therapeutics Receives 2026 Prix Galien USA Award for AVLAYAH® (tividenofusp alfa-eknm) as Best Biotechnology Product
- Utah Business, Government Leaders Deepen Connections in Ireland
- Co-Diagnostics’ Joint Venture CoSara Diagnostics Announces Publication of Peer-Reviewed HPV Screening Study Using CoSara’s SARAGENE® Test
